Premium Information is available for this item - Upgrade for $1 a day
5985-01-642-5543
Directional Coupler
5985016425543 016425543 CB1-30NF 9R8-1848/01.01
An item specifically designed to be inserted into a transmission line, waveguide or coaxial transmission line to provide a suitable test outlet. The test signal is attenuated to a predetermined value. View more Directional Coupler
January 2023
2

Marketplace 5985-01-642-5543
Request a Quotation from participating marketplace vendors
Related Documents 5985-01-642-5543 1+ Documents (More...)
5985-01-642-5543 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-59/fsc-5985/us 5985-01-642-5543
RQST Updated Every Day 5985-01-642-5543 RQST NE Related Documents 5985-01-642-5543 1+ Documents
Restrictions 5985-01-642-5543
5985-01-642-5543 is a Directional Coupler Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 5985-01-642-5543
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 5985-01-642-5543
- United Kingdom (ZK01)
- Effective Date:
- 1 Mar 2015
Approved Sources 5985-01-642-5543
- Part Number
- Manufacturer
- Status
- CB1-30NF
- Manufacturer
- 0D2L5 - Microwave Communications (Active)
- Primary Buy
- Primary Buy
- 9R8-1848/01.01
- U0T24 - Selex Es Limited (Active)
- Secondary Buy
- Secondary Buy
NATO Stock Numbers Related to 5985-01-642-5543
Freight Information 5985-01-642-5543
5985-01-642-5543 has freight characteristics.. 5985-01-642-5543 has a variance between NMFC and UFC when transported by rail and the description should be consulted.